Iwasaki, Eisuke

写真a

Affiliation

School of Medicine, Department of Internal Medicine (Gastroenterology and Hepatology) (Shinanomachi)

Position

Assistant Professor/Senior Assistant Professor

Related Websites

External Links
Page Top ▲

Profile 【 Display / hide 】

  • Eisuke Iwasaki M.D., Ph.D. is a specialist in the diagnosis and treatment of pancreat-biliary disease. He focus especially on endoscopic treatment using EUS and ERCP. His research themes are clinical practice of severe acute pancreatitis, IgG4 related diseases, interventional EUS and endoscopic ampullectomy.

Page Top ▲

Message from the Faculty Member 【 Display / hide 】

  • I have been responsible for the education of medical students since 2015 up to the present.　I continue to work together with Dr. Sugimoto to ensure that medical students have an accomplished clinical training.

Page Top ▲

Other Disclosed Information 【 Display / hide 】

  • 　

Page Top ▲

Profile Summary 【 Display / hide 】

Page Top ▲

Career 【 Display / hide 】

  • 2015.04

    慶應義塾大学医学部内科学教室, 消化器内科, 助教

  • 2015.05
    -
    2017.02

    Department of Internal Medicine, Keio University School of Medicine, Division of Gastroenterology, Assistant Professor

  • 2017.03
    -
    Present

    Department of Internal Medicine, Keio University School of Medicine, Division of Gastroenterology, Assistant Professor

Page Top ▲

Licenses and Qualifications 【 Display / hide 】

  • ICLS（Immediate Cardiac Life Support) Instructor, 2018.08

  • A certified occupational physician, 2019年11月30日更新, 2010.11

Page Top ▲
 

Research Areas 【 Display / hide 】

  • Life Science / Gastroenterology

Page Top ▲

Research Themes 【 Display / hide 】

  • Multicenter retrospective study in endoscopic papillectomy for duodenal ampullary tumor, 

    2020.03
    -
    2024.03

    　View Summary

    To evaluate the efficacy, prognosis, and treatment of endoscopic papillectomy (EP).
    UMIN000040288

  • Examination of the usefulness of probe type confocal laser endomicroscopy for duodenum, biliary tract system and pancreas disease., 

    2017.01
    -
    2021.03

    　View Summary

    To clarify the usefulness of probe type confocal laser endomicroscopy for duodenum, biliary tract system and pancreas disease.

  • Evaluation of exhaled carbon dioxide monitoring during endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography, 

    2016.08
    -
    2018.12

    　View Summary

    to determine whether capnographic monitoring reduces the incidence of hypoxemia during endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography

  • Comparison of the electricity method for endoscopic papillectomy., 

    2016.03
    -
    2018.03

    　View Summary

    To compare of frequency of complications for endoscopic papillectomy.

  • Examination of the flow of pancreatic juice with pancreatic disease using cine dynamic MRCP with spatially selective inversion recovery pulse., 

    2015.10
    -
    2020.03

    　View Summary

    To evaluate the flow of pancreatic juice with Chronic pancreatitis,Pancreatic cancer,IPMN,Autoimmune pancreatitis

Page Top ▲

Proposed Theme of Joint Research 【 Display / hide 】

  • Clinical study about ERCP or EUS

  • 胆膵悪性腫瘍の内視鏡的治療 採取された検体を用いた基礎研究など

Page Top ▲
 

Papers 【 Display / hide 】

  • Serum IgG4-negative and IgG4-positive type 1 autoimmune pancreatitis present with different clinicopathological features: An analysis of a nationwide survey in Japan

    Sano T., Kikuta K., Takikawa T., Matsumoto R., Okazaki K., Takeyama Y., Masamune A., Ikeura T., Itoi T., Ito T., Inoue D., Irisawa A., Ueki T., Uehara T., Uchida K., Kubota K., Kodama Y., Naitoh I., Nakazawa T., Nishino T., Notohara K., Hirooka Y., Fujimori N., Nakai Y., Kamisawa T., Motoya M., Tomoyuki Ushijima K.S., Fukasawa M., Ueno M., Okuwaki K., Uza N., Asada M., Mukai T., Kudo Y., Uetsuki K., Mitoro A., Watanabe H., Terai S., Hayashi K., Imamura Y., Haba S., Hara K., Fujisawa T., Iwasaki E., Okumura F., Kawaji Y., Kitano M., Nagahama M., Hirano A., Aruga Y., Yamamoto S., Inui K., Kubota Y., Takahashi K., Sakagami J., Kobayashi T., Miraki T., Watanabe T., Sato H., Takeda Y., Satoh M., Kobashigawa K., Chiba M., Tamura T., Sawada N., Mizukami K., Sekine M., Unno J., Ishizawa T., Funayama H., Hatayama K., Miyakawa H., Sakai T., Kuwatani M., Toki M., Toyokawa T., Hashimoto S., Iwashita Y., Sato A., Kato H., Takatori H., Iizawa Y., Iwashita T., Kondo H., Sato Y., Tanabe M., Ogura T., Yamamoto K., Masaka T., Setsuda M., Sano T., Matsubara S., Kitamura K., Iwata K., Shirahata N., Hagiwara H., Yoshida M., Yokota T., Shigoka H., Kaneko N.

    Pancreatology 25 ( 1 ) 82 - 88 2025.02

    Joint Work,  ISSN  14243903

    　View Summary

    Background/Objective: Elevated serum IgG4 (sIgG4) is a useful diagnostic marker of type 1 autoimmune pancreatitis (AIP). This study aimed to clarify the clinicopathological characteristics of the type 1 AIP patients without elevated sIgG4 levels. Methods: We analyzed the clinical data of patients registered in a nationwide epidemiological survey in Japan. AIP was diagnosed according to the International Consensus Diagnostic Criteria. Patients with sIgG4 levels ≥135 mg/dl at the diagnosis were classified as sIgG4-positive AIP, and those with sIgG4 levels <135 mg/dl were as sIgG4-negative AIP. Results: A total of 1285 patients with AIP were enrolled in this study; 1128 (87.8 %) had sIgG4-positive AIP and 157 (12.2 %) had sIgG4-negative AIP. Compared to patients with sIgG4-positive AIP, those with sIgG4-negative AIP more frequently experienced inflammatory bowel diseases (3.8 % vs. 0.4 %), and less frequently developed extrapancreatic lesions (53.5 % vs. 72.3 %), including sclerosing cholangitis (30.6 % vs. 40.7 %) and sialadenitis/dacryoadenitis (5.1 % vs. 24.7 %). Histopathological examinations were performed more frequently in patients with sIgG4-negative AIP. The criterion of abundant IgG4-positive plasma cells was less frequently fulfilled by patients with sIgG4-negative AIP (28.0 % vs. 43.1 %). A Kaplan-Meier analysis showed that relapse occurred less frequently in patients with sIgG4-negative AIP (P = 0.006). Results were similar even if the patients with AIP-not otherwise specified (n = 45) were excluded. Conclusions: Patients with sIgG4-negative type 1 AIP and those with sIgG4-positive type 1 AIP present with different clinicopathological features which suggests heterogeneity of patients with type 1 AIP. Low serum IgG4 levels could indicate low disease activity in type 1 AIP.

  • Capnographic monitoring using a novel mainstream system during endoscopic ultrasound and endoscopic retrograde cholangiopancreatography: A prospective randomized controlled trial

    Takimoto Y., Iwasaki E., Horibe M., Fukuhara S., Minami K., Kawasaki S., Masaoka T., Ogata H., Bazerbachi F., Kanai T.

    Journal of Hepato-Biliary-Pancreatic Sciences  2025

    Joint Work,  ISSN  18686974

    　View Summary

    Background/Purpose: Insufficient studies exist on capnography efficacy during endoscopic ultrasound or endoscopic retrograde cholangiopancreatography, and no definitive conclusions have been drawn. To evaluate the feasibility and efficacy of a novel mainstream capnography using an over-the-biteblock end-tidal CO2 (EtCO2) detector in decreasing the risk of hypoxemia during endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP). Methods: Patients undergoing EUS or ERCP with conscious sedation at a single Japanese center were randomized to a control or a novel capnography monitored (intervention) group in a 1:1 ratio. Hypoxemia correction maneuvers were pursued if the oxygen saturation decreased to <92% in the control or intervention group and if a 15-s suspension of EtCO2 wave occurred in the intervention group. The primary outcome was the incidence of hypoxemic events, defined as oxygen saturation <90%, during the procedures. Secondary outcomes included technical feasibility of EUS and ERCP with the use of this novel over-the-biteblock monitor. Results: In total, 250 patients were enrolled without dropouts or missing data (control group: 125; capnography group: 125). There was no significant difference in the incidence of hypoxemia between the control and capnography groups (29.6% [37/125] vs. 26.4% [33/125]; p =.573). The estimated odds ratio was 0.925 (95% confidence interval: 0.708–1.208). The EtCO2 concentration was successfully captured without impeding endoscopic maneuvers from the beginning to the end of the procedure in all patients. Conclusions: Although the novel mainstream capnography with an over-the-biteblock EtCO2 detector captures the EtCO2 concentration in EUS or ERCP under conscious sedation, it does not lead to the prevention of hypoxemia.

  • Normal saline versus Ringer’s solution and critical-illness mortality in acute pancreatitis: a nationwide inpatient database study

    Horibe M., Kayashima A., Ohbe H., Bazerbachi F., Mizukami Y., Iwasaki E., Matsui H., Yasunaga H., Kanai T.

    Journal of Intensive Care (Journal of Intensive Care)  12 ( 1 ) 27 2024.12

    Joint Work,  ISSN  2052-0492

    　View Summary

    Background: Fluid resuscitation is fundamental in acute pancreatitis (AP) treatment. However, the optimal choice between normal saline (NS) and Ringer's solution (RS), and its impact on mortality in critically ill patients, remains controversial. This retrospective cohort study, utilizing a national Japanese inpatient database, investigates this question. Methods: Using the Japanese Diagnosis Procedure Combination database between July 2010 and March 2021, we identified adult patients hospitalized in intensive care units (ICU) or high-dependency care units (HDU) for AP who survived at least three days and received sufficient fluid resuscitation (≥ [10 ml/kg/hr*1 h + 1 ml/kg/hr*71 h] ml) within three days of admission including emergency room infusions. Patients were classified into groups based on the predominant fluid type received: the NS group (> 80% normal saline) and the RS group (> 80% Ringer's solution). Propensity score matching was employed to reduce potential confounding factors and facilitate a balanced comparison of in-hospital mortality between the two groups. Results: Our analysis included 8710 patients with AP. Of these, 657 (7.5%) received predominantly NS, and 8053 (92.5%) received predominantly RS. Propensity score matching yielded 578 well-balanced pairs for comparison. The NS group demonstrated significantly higher in-hospital mortality than the RS group (12.8% [474/578] vs. 8.5% [49/578]; risk difference, 4.3%; 95% confidence interval, 0.3% to 8.3%). Conclusions: In patients admitted to ICU or HDU with AP receiving adequate fluid resuscitation, RS can be a preferred infusion treatment compared to NS.

  • Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma.

    Tamagawa H, Fujii M, Togasaki K, Seino T, Kawasaki S, Takano A, Toshimitsu K, Takahashi S, Ohta Y, Matano M, Kawasaki K, Machida Y, Sekine S, Machinaga A, Sasai K, Kodama Y, Kakiuchi N, Ogawa S, Hirano T, Seno H, Kitago M, Kitagawa Y, Iwasaki E, Kanai T, Sato T

    Nature cell biology 26 ( 10 ) 1759 - 1772 2024.09

    Joint Work,  ISSN  1465-7392

    　View Summary

    Human pancreatic cancer is characterized by the molecular diversity encompassing native duct-like and squamous cell-like identities, but mechanisms underlying squamous transdifferentiation have remained elusive. To comprehensively capture the molecular diversity of human pancreatic cancer, we here profiled 65 patient-derived pancreatic cancer organoid lines, including six adenosquamous carcinoma lines. H3K27me3-mediated erasure of the ductal lineage specifiers and hijacking of the TP63-driven squamous-cell programme drove squamous-cell commitment, providing survival benefit in a Wnt-deficient environment and hypoxic conditions. Gene engineering of normal pancreatic duct organoids revealed that GATA6 loss and a Wnt-deficient environment, in concert with genetic or hypoxia-mediated inactivation of KDM6A, facilitate squamous reprogramming, which in turn enhances environmental fitness. EZH2 inhibition counterbalanced the epigenetic bias and curbed the growth of adenosquamous cancer organoids. Our results demonstrate how an adversarial microenvironment dictates the molecular and histological evolution of human pancreatic cancer and provide insights into the principles and significance of lineage conversion in human cancer.

  • Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis.

    Kayashima A, Sujino T, Fukuhara S, Miyamoto K, Kubosawa Y, Ichikawa M, Kawasaki S, Takabayashi K, Iwasaki E, Kato M, Honda A, Kanai T, Nakamoto N

    Hepatology communications 8 ( 6 )  2024.06

    Joint Work

display all >>

Page Top ▲

Papers, etc., Registered in KOARA 【 Display / hide 】

Page Top ▲

Reviews, Commentaries, etc. 【 Display / hide 】

  • EUS-FNAガイドライン

    入澤 篤志, 蘆田 玲子, 伊佐山 浩通, 石田 和之, 岩崎 栄典, 岩下 拓司, 潟沼 朗生, 菅野 敦, 塩見 英之, 竹中 完, 中井 陽介, 引地 拓人, 安田 一朗, 植木 敏晴, 赤星 和也, 糸井 隆夫, 松田 浩二, 良沢 昭銘, 能登原 憲司, 藤城 光弘, 五十嵐 良典, 田中 信治, 日本消化器内視鏡学会

    Gastroenterological Endoscopy ((一社)日本消化器内視鏡学会)  66 ( 9 ) 1739 - 1806 2024.09

    Joint Work,  ISSN  0387-1207

    　View Summary

    日本消化器内視鏡学会は,「Minds診療ガイドライン作成マニュアル2020 ver.3.0」に従い,EBMに基づいた「EUS-FNAガイドライン」を作成した.EUS-FNAは,優れた病変描出能を有するEUSの技術を応用し,経消化管的に超音波で病変を確認しながら穿刺により病理検体を採取する手技であり,本邦では2010年の保険収載以降,広く施行されている.執筆はCQ(clinical question)形式とし,必要に応じてBQ(background question)・FRQ(future research question)を設けた.なお,一部のCQにおいては,レベルの高いエビデンスが少ないため,専門家のコンセンサスを重視せざるを得なかった.本ガイドラインは,EUS-FNAの概略,適応・偶発症,診断能,手技の4項目を柱に構築し,現時点での指針とした.(著者抄録)

  • 【肝門部胆管癌～診断と治療の標準化へ向けて～】術前診断と内科的治療(緩和的治療も含めて)　両葉ドレナージvs.片葉ドレナージ

    早川 宇宙, 岩崎 栄典

    胆と膵 (医学図書出版(株))  45 ( 6 ) 575 - 579 2024.06

    Joint Work,  ISSN  0388-9408

    　View Summary

    肝門部悪性胆管狭窄(HMBO)に対する内視鏡的ドレナージは近年,技術的な進歩とデバイスの進歩により経皮的ドレナージを代替する形で,黄疸や胆管炎の改善に重要な役割を担うようになった。HMBOのドレナージ戦略は切除可能例(術前症例)と切除不能例では異なる。肝門部胆管の解剖は総胆管から胆管枝が複雑に分かれ,さらに破格も多いうえに,腫瘍の範囲にあわせて適切なドレナージ方法を選択する必要がある。その中でもHMBOに対するドレナージ範囲として片葉,両葉のどちらかを選択するか議論の余地がある。ドレナージ領域を広く取ったほうが感染予防や肝予備能が保たれることは直感的に理解できるものの,細い総胆管から複数の枝にドレナージを留置するとなると技術的問題やデバイス径により制限が生じうる。本稿では両葉・片葉ドレナージについて,最近のエビデンスを概説したい。(著者抄録)

  • 【患者さんからよく尋ねられる内科診療のQuestion】(第8章)肝・胆・膵　[25歳男性,急性膵炎]急性膵炎で入院しました.再発しないか心配です

    岩崎 栄典

    内科 ((株)南江堂)  133 ( 4 ) 875 - 878 2024.04

    Joint Work,  ISSN  0022-1961

  • ERCP後膵炎ガイドライン2023

    糸井 隆夫, 池浦 司, 入澤 篤志, 岩崎 栄典, 潟沼 朗生, 北村 勝哉, 竹中 完, 竹山 宜典, 廣田 衛久, 正宗 淳, 真弓 俊彦, 向井 俊太郎, 森實 敏夫, 安田 一朗, 良沢 昭銘, 吉田 雅博, 伊藤 鉄英, 安田 健治朗, 伊藤 嵩志, 岩野 光佑, 圓谷 俊貴, 鎌田 研, 茅島 敦人, 小岩井 明信, 谷坂 優樹, 豊永 啓翔, 中丸 洸, 永島 一憲, 林 伸彦, 堀部 昌靖, 本間 俊裕, 水出 雅文, 三長 孝輔, 山宮 知, 日本膵臓学会急性膵炎調査研究委員会急性膵炎分科会, 改訂ERCP後膵炎ガイドライン作成委員会

    膵臓 ((一社)日本膵臓学会)  39 ( 2 ) 79 - 158 2024.04

    Joint Work,  ISSN  0913-0071

  • 十二指腸乳頭部腫瘍の内視鏡的マネジメント

    岩崎 栄典, 川崎 慎太郎, 金井 隆典

    Gastroenterological Endoscopy ((一社)日本消化器内視鏡学会)  66 ( 3 ) 243 - 258 2024.03

    Joint Work,  ISSN  0387-1207

    　View Summary

    十二指腸乳頭部腫瘍は内視鏡スクリーニングが広く行われるようになったことから無症状で発見されることが増えている.以前は黄疸をきたした進行癌の状態で発見されることが多く開腹手術による膵頭十二指腸切除が第一選択であった.最近は十二指腸乳頭部腫瘍に対して内視鏡的乳頭切除術が積極的に行われるようになった.また,十二指腸乳頭部腫瘍の診断には十二指腸乳頭部近傍の微細な腫瘍浸潤を評価するために超音波内視鏡の有用性が報告されている.日本消化器内視鏡学会および欧州内視鏡学会から内視鏡的乳頭切除のガイドラインが出版され,現在のエビデンスをもとにした診断と治療方法について標準的方針が提示された.本稿ではさらに最近の新たなエビデンスと論文をレビューしたい.(著者抄録)

display all >>

Page Top ▲

Presentations 【 Display / hide 】

  • Capnographic monitoring using a novel mainstream system during endoscopic ultrasound and endoscopic retrograde cholangiopancreatography: a prospective randomized controlled trial

    Iwasaki, Eisuke; Takimoto, Yoichi; Horibe, Masayasu; Kayashima, Atsuto; Kawasaki, Shintaro; Machida, Yujiro; Masaoka, Tatsuhiro; Ogata, Haruhiko; Bazerbachi, Fateh; Kanai, Takanori

    (Chicago) , 

    2023.05
    , 

    Poster presentation

  • Clinical outcomes of endoscopic papillectomy; a large multicenter retrospective study

    E. Iwasaki, H. Kawashima, A. Katanuma, K. Yamamoto, S. Ryozawa, S. Hashimoto, T. Yamao, K. Kubota, T. Iwai, K. Hara, H. Shiomi, K. Ikezawa, J. Ushio, H. Kato, N. Fujimori, K. Nakahara, E. Ozawa, Y. Nakai, H. Isayama, Y. Igarashi, N. Fujita, T. Ueki, K. Inui . A. Kayashima, T. Itoi

    UEGW2022, 

    2022.10
    , 

    Poster presentation

  • Ampullary Neoplasia: Is ESD Possible? Or is Endoscopic Ampullectomy and Wide-field EMR the Way?

    Eisuke Iwasaki

    DDW 2022 (SanDiego) , 

    2022.05
    , 

    Oral presentation (invited, special), ASGE

  • Predicting outcomes using an early hospitalization pancreatitis activity scoring system: a large prospective multicenter study

    Masayasu Horibe, Eisuke Iwasaki et al.

    DDW 2022 (SanDiego) , 

    2022.05
    , 

    Oral presentation (general)

  • 内視鏡的乳頭部腫瘍切除術の断端病理診断とフォロー計画

    川崎慎太郎、岩崎栄典、緒方晴彦、金井隆典

    日本消化器内視鏡学会総会　2022 (京都) , 

    2022.05
    , 

    Oral presentation (general), 日本消化器内視鏡学会

display all >>

Page Top ▲

Research Projects of Competitive Funds, etc. 【 Display / hide 】

  • Exploratory research on the development of new treatments for biliary tract cancer: establishment of patient-derived organoid bank and analysis of bile microbiome

    2022.04
    -
    2025.03

    Japan Society for the Promotion of Science (JSPS), The Ministry of Education,Culuture,Sports,Science and Technology (MEXT), Grant-in-Aid for Scientific Research, Eisuke Iwasaki, Grant-in-Aid for Scientific Research（Ｃ）, Research grant, Principal investigator

    　View Summary

    悪性腫瘍に対する世界的な基礎研究、臨床研究の進歩にも関わらず、胆道癌は難治かつ生命予後不良であり、発生メカニズム、危険因子を解明し、革新的な治療の開発が必要である。標準的な抗がん剤に高度の耐性があり、個別化医療、がんゲノム診療を始めとした新しい治療戦略を構築する必要がある。本研究では胆汁を用いた胆道癌オルガイドバンクを樹立し、胆道癌の生物学的な特性を明らかにし、今後の個別化医療、創薬への基盤となる研究を行う。また、発がん危険因子の探索のために、環境要因である胆道細菌叢、胆汁酸を解析することにより生体内環境リスクに準じた早期発見、予防的な介入の開発への基盤的研究を行いたい。

  • 胆膵がんオルガノイドをもちいた薬剤感受性試験確立と薬剤応答性メカニズムの解明

    2019.04
    -
    2022.03

    Japan Society for the Promotion of Science (JSPS), The Ministry of Education,Culuture,Sports,Science and Technology (MEXT), Grant-in-Aid for Scientific Research, Eisuke Iwasaki, Grant-in-Aid for Scientific Research（Ｃ）, Research grant, Principal investigator

    　View Summary

    難治かつ生命予後不良な胆膵がん疾患における治療成績改善のため、個別化治療の導入が望まれている。研究分担者である佐藤俊朗が世界で初めて確立した三次元組織構造体（オルガノイド）培養をHigh-throughput screening薬剤感受性試験に応用することで、比較的短時間かつ高い精度で効率の良い薬剤感受性試験が実現可能である。手術検体や超音波内視鏡下生検より現在得られたごく微量の腫瘍組織よりオルガノイドを樹立し、バンク化を進めている。胆膵がんオルガノイドバンクより薬剤感受性試験技術を確立させ、臨床データとの相関性を検討する。また薬剤感受性データと全エキソン同定、遺伝子発現アレイ解析などのin vitroデータとの相関解析の他、 CRISPR-Cas9システムを用いたゲノム編集技術を応用し、薬剤応答性の評価方法を確立することで個別化医療への応用、 創薬分野への応用を目指す。

  • Establishment of drug screening test using patient-derived cancer organoid for refractory pancreato-biliary malignancies

    2016.04
    -
    2019.03

    Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research, Eisuke Iwasaki, Grant-in-Aid for Scientific Research（Ｃ）, Research grant, Principal investigator

    　View Summary

    難治かつ生命予後不良な胆膵悪性腫瘍における診断治療の革新のため，オーダーメイド治療の導入が望まれている．研究分担者である佐藤らが世界で初めて確立した三次元組織構造体（オルガノイド）培養とHigh-throughput screening（HTS）を応用することで，比較的短時間かつ高い精度で効率の良い薬剤感受性試験が実現可能である．超音波内視鏡下生検より得たごく微量の腫瘍組織よりのオルガノイド培養方法の確立，全エキソン同定，HTS による薬剤感受性試験の確立，
    in vivo でゼノグラフトを用いた評価をおこなう．世界初のオルガノイド培養を用いたオーダーメイド治療選択の実現に向けた基礎的な研究・技術開発を目的とする．

  • 難治性疾患等政策研究事業（難治性疾患政策研究事業）オールジャパン体制によるIgG4関連疾患の診断基準並びに診療指針の確率を目指す研究

    2023.04
    -
    2026.03

    厚生労働科学研究費, Research grant, Coinvestigator(s)

  • 難治性疾患等政策研究事業（難治性疾患政策研究事業）「IgG4関連疾患の診断基準ならびに治療指針の確立を目指す研究」

    2017.04
    -
    2019.03

    厚生労働省, Health and Labour Sciences Research Grants, Research grant, Coinvestigator(s)

Page Top ▲

Awards 【 Display / hide 】

  • Journal of Hepato-Biliary-Pancreatic Sciences Best Reviewer Award 2022

    2023.07, JSHBPS

    Type of Award： Honored in official journal of a scientific society, scientific journal

  • Journal of Hepato-Biliary-Pancreatic Sciences Best Reviewer Award 2021

    2022.07, JSHBPS

    Type of Award： Honored in official journal of a scientific society, scientific journal

Page Top ▲
 

Courses Taught 【 Display / hide 】

  • LECTURE SERIES, INTERNAL MEDICINE (GASTROENTEROLOGY)

    2024

  • PATHOPHYSIOLOGICAL ISSUES IN CHRONIC CARE

    2023

  • LECTURE SERIES, INTERNAL MEDICINE (GASTROENTEROLOGY)

    2023

  • LECTURE SERIES, INTERNAL MEDICINE

    2023

  • INTRODUCTION TO CLINICAL CLERKSHIPS

    2023

display all >>

Page Top ▲

Courses Previously Taught 【 Display / hide 】

  • lecture of gastroenterology

    Keio University School of Medicine

    2021.04
    -
    2022.03
    , 

    Autumn Semester, Lecture, Within own ｆaculty, 3h, 120people

  • lecture of chronic diseases

    Keio University Faculty of Nursing And Medical Care

    2021.04
    -
    2022.03
    , 

    Spring Semester, Lecture, Within own ｆaculty, 1h

  • lecture of gastroenterology

    Keio University School of Medicine

    2020.04
    -
    2021.03
    , 

    Autumn Semester, Lecture, Within own ｆaculty, 3h, 120people

  • 内科診断学実習（OSCE講義）

    慶應義塾大学医学部

    2019.04
    -
    2020.03
    , 

    Autumn Semester, Laboratory work/practical work/exercise, Within own ｆaculty, 20people

  • 消化器内科学　講義

    慶應義塾大学医学部

    2019.04
    -
    2020.03
    , 

    Spring Semester, Lecture, Within own ｆaculty, 120people

display all >>

Page Top ▲

Educational Activities and Special Notes 【 Display / hide 】

  • PostCC OSCE委員

    2019.04
    -
    Present

  • OSCE委員

    2016.02
    -
    Present

    , Special Affairs

    　View Details

    OSCE試験腹部担当としてステーションリーダーとなり、評価者の基準を統一にすべく指導を行った。

  • カリキュラム委員会

    2015.04
    -
    Present

    , Device of Educational Contents

    　View Details

    カリキュラム委員として活動

Page Top ▲
 

Social Activities 【 Display / hide 】

  • 第114回日本消化器内視鏡学会関東支部例会　ハンスオンセミナー講師

    日本消化器内視鏡学会,  (シェーンバッハ・サボー)

    , 
    2022.06

  • 第１回JDDWハンズオントレーニングセミナー　2021

    日本消化器内視鏡学会,  (神戸国際会議場)

    , 
    2021.11

  • 第108回日本消化器内視鏡学会関東支部例会　ハンスオンセミナー講師

    日本消化器内視鏡学会,  (シェーンバッハ・サボー)

    , 
    2019.05

  • JDDWハンズオントレーニングセミナー　2017

    日本消化器内視鏡学会,  (福岡国際センター)

    , 
    2017.11
Page Top ▲

Memberships in Academic Societies 【 Display / hide 】

  • 日本消化器病学会, 

    2003.07
    -
    Present

  • Japan Gastroenterological Endoscopy Society, 

    2003.07
    -
    Present

  • 日本内科学会, 

    2001.04
    -
    Present
Page Top ▲

Committee Experiences 【 Display / hide 】

  • 2022.02
    -
    Present

    改訂ERCP後膵炎診療ガイドライン作成委員, 日本膵臓学会

  • 2021.07
    -
    Present

    EUS-FNAガイドライン作成委員, 日本消化器内視鏡学会

    　View Remarks

    https://www.jges.net/medical/about/list/committee#esufna

  • 2021.05
    -
    Present

    IgG4関連消化管病変に関する調査研究 Woriking Gruop, 厚生労働省難治疾患研究班

    　View Remarks

    https://www.nanbyou.or.jp/entry/4505

  • 2020.10
    -
    Present

    第113回日本消化器内視鏡学会関東支部例会　プログラム委員, 日本消化器内視鏡学会

    　View Remarks

    http://www.jges-k.umin.jp/113shibureikai/outline.html

  • 2020.08
    -
    Present

    日本肝胆膵外科学会　編集委員会　委員, 日本肝胆膵外科学会

display all >>

Page Top ▲